Inhibition of telomerase activity by NME2: impact on metastasis suppression?

Anirban Kar1, Shantanu Chowdhury

  • 1Proteomics and Structural Biology Unit, CSIR-Institute of Genomics and Integrative Biology, Mathura Road, New Delhi, 110025, DELHI, India.

Insights

Non-metastatic 2 (NME2) protein suppresses cancer metastasis by inhibiting telomerase activity. NME2

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Non-metastatic 2 (NME2) exhibits anti-metastatic properties in various cancers.
  • The precise mechanisms of NME2-mediated metastasis suppression remain unclear.
  • Telomerase's role in metastasis is increasingly recognized but poorly understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which NME2 suppresses cancer metastasis.
  • To investigate the interplay between NME2, telomere maintenance, and telomerase activity in cancer cells.

Main Methods:

  • Western blotting
  • Immunoprecipitation
  • Telomerase activity assays
  • Telomere length analysis

Main Results:

  • NME2 was found to localize at telomere ends.
  • NME2 directly associates with telomerase.
  • NME2 inhibits telomerase activity in cancer cells, impacting telomere length.

Conclusions:

  • NME2 acts as a novel telomerase inhibitor, contributing to its anti-metastatic function.
  • Targeting the NME2-telomerase interaction may offer new therapeutic strategies for preventing cancer metastasis.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.7K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
28.9K
Telomeres and Telomerase02:41

Telomeres and Telomerase

8.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K